Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (198)	6/3/1998 12:32:00 PM
From: mesaone	Respond to of 337

does anyone know what is going on today? volume is really up there.. who is buying? why are they buying. are there any new rumors about being purchased??

To: scaram(o)uche who wrote (198)	6/16/1998 11:31:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 337

sounds sort of relevant....... BLOOD PRODUCTS ADVISORY COMMITTEE DATE AND TIME: June 18 and 19, 8:00 a.m. LOCATION: DoubleTree Hotel, Plaza I and II, 1750 Rockville Pike, Rockville, MD. CONTACT: Linda A. Smallwood, Ph.D., 301-827-3514. On June 18, the committee will hear updates on hepatitis C recipient notification and partner deferral of xenotransplantation recipients, and discuss information provided on the Blood Action Plan, Immune Globulin Intravenous supply issues, and Plasma Inventory Hold. In the afternoon, the Committee will discuss standard testing for human immunodeficiency virus (HIV) variants.